EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN INTERSTITIAL PNEUMONIA WITH SERIOUS RESPIRATORY FAILURE SECONDARY TO SARS-COV-2 INFECTION (COVID-19): COHORT STUDY (TOCICOV-19)

First published 31/03/2020

Last updated 22/02/2024

EU PAS number:

EUPAS34415

Study

Finalised

Documents

Study protocol

Initial protocol

PROTOCOLO ESTUDIO DE COHORTES TOCI VERSION 0_REV

English (866.64 KB - PDF) View document

Updated protocol

PROTOCOLO ESTUDIO DE COHORTES TOCI VERSION 1.0 08042020

First published: 22/02/2024

English (403.65 KB - PDF) View document

Study results

40121_2020_Article_373

English (886.97 KB - PDF) View document

Study report

Other information

Publications

Study publications

Secondary tabs